Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer - Wikidata - wikimedia - TriplyDB

Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer

Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer

http://www.wikidata.org/entity/Q56965679

about

Biosynthesis and Functional Significance of Peripheral Node Addressin in Cancer-Associated TLO Tertiary Lymphoid Organs in Cancer Tissues How Follicular Dendritic Cells Shape the B-Cell Antigenome Ectopic lymphoid follicles: inducible centres for generating antigen-specific immune responses within tissues Control of CD8 T-Cell Infiltration into Tumors by Vasculature and Microenvironment Therapeutic Lymphoid Organogenesis in the Tumor Microenvironment Update in Lung Cancer 2014 Understanding Immune Cells in Tertiary Lymphoid Organ Development: It Is All Starting to Come Together Tertiary Lymphoid Structures in Cancers: Prognostic Value, Regulation, and Manipulation for Therapeutic Intervention Antigen-Presenting Cells and Antigen Presentation in Tertiary Lymphoid Organs From mice to humans: developments in cancer immunoediting Orchestration of angiogenesis by immune cells B cells and the humoral response in melanoma: The overlooked players of the tumor microenvironment B cells and ectopic follicular structures: novel players in anti-tumor programming with prognostic power for patients with metastatic colorectal cancer Characterisation and prognostic value of tertiary lymphoid structures in oral squamous cell carcinoma Prognostic value of immune cell infiltration, tertiary lymphoid structures and PD-L1 expression in Merkel cell carcinomas.Tertiary Lymphoid Structure-Associated B Cells are Key Players in Anti-Tumor Immunity.Cellular and molecular immunology of lung cancer: therapeutic implications.A high density of tertiary lymphoid structure B cells in lung tumors is associated with increased CD4(+) T cell receptor repertoire clonality COPD and squamous cell lung cancer: aberrant inflammation and immunity is the common link.Tumor infiltration by Tbet+ effector T cells and CD20+ B cells is associated with survival in gastric cancer patients.Increased expression of A Proliferation-inducing Ligand (APRIL) in lung leukocytes and alveolar epithelial cells in COPD patients with non small cell lung cancer: a possible link between COPD and lung cancer?Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma.Molecular and epigenetic features of melanomas and tumor immune microenvironment linked to durable remission to ipilimumab-based immunotherapy in metastatic patients Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression.Intratumoral injection of a CpG oligonucleotide reverts resistance to PD-1 blockade by expanding multifunctional CD8+ T cells.Tumor-infiltrating lymphocyte composition, organization and PD-1/ PD-L1 expression are linked in breast cancer.Downregulation of the neonatal Fc receptor expression in non-small cell lung cancer tissue is associated with a poor prognosis.Immunotherapy biomarkers 2016: overcoming the barriers.Shaping of an effective immune microenvironment to and by cancer cells.The non-small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcome Tertiary lymphoid tissue in the tumor microenvironment: from its occurrence to immunotherapeutic implications.Regulatory B cells in anti-tumor immunity.Group 3 innate lymphoid cells: regulating host-commensal bacteria interactions in inflammation and cancer.Tertiary Lymphoid Structures: An Anti-tumor School for Adaptive Immune Cells and an Antibody Factory to Fight Cancer?Local and systemic immunity predict survival in patients with pulmonary sarcomatoid carcinoma.Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers.NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures.Lymphotoxin signalling in tertiary lymphoid structures and immunotherapy.Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy.

P2860

Q26739445-D64D390F-E714-4445-BB89-CA4F3535123B Q26742168-84683C3F-3304-46F5-B020-ABE7645E069C Q26742173-2F9F0885-E937-4803-BF7A-CC3C3BE8A9B0 Q26778348-D7921575-7E63-4495-8927-E3D8D8FD4CAC Q26799117-3AC8E32D-321F-4B60-AC52-07946023F368 Q26799123-2D975988-D099-4924-B43C-3E35F4501208 Q27027385-6E32D07F-E2BF-4A2E-A782-CD7348E602A9 Q28067648-5770A9BB-E48E-4930-8190-6C54D6E0F985 Q28073895-2DDBA9A9-150E-4D81-BD38-9E70DD8234EC Q28079346-D233A30A-8933-4A69-A0DD-F7A623139AA9 Q28088304-3F76EB9E-8EFA-4C8E-8EA0-B4DDEDEF0446 Q28389236-1474BDC3-C93E-4311-B99D-AAA2A09EB82C Q33632113-D262E1BA-62DB-458F-824D-B009DEFD18D9 Q33721433-E659E068-91C4-4D38-B0B7-214357A061AB Q34105741-A7A1E12E-693B-4CE0-A243-DAB963705E39 Q34733445-5DCC1891-2FCB-4ECE-A8E1-9F1ED71A1420 Q35110486-A717892D-A2CF-4A80-A8F7-D0EC5B73A506 Q36130505-54CD15A8-1329-4EEC-8ABD-D8AA929CF1CB Q36256308-BFA9ADE1-CD9F-4483-AE5F-1E5C4E1C02CE Q36546997-749B7332-3AC5-4C94-872D-B9EBF1BC0E9B Q36710911-102DA40F-1C20-4525-BF0B-E6FE76E18C76 Q36760903-157B0691-8F7E-4F09-9397-1484F4F197A4 Q36821138-95C960ED-5BFA-47A5-8644-7B7175C1E516 Q37148418-6BFB6D39-4F78-4376-9C2A-3377C235103E Q37356734-87E4527A-4103-498C-9D93-171BAE6002D9 Q37469720-E446331C-4DC3-45AF-AACA-1E431AC3BB69 Q37616487-8136D58F-5AFB-45CD-AA83-9473E18E9DB4 Q37688076-E6DA627E-F666-4835-9758-821B053F82DD Q37713438-817E8AC3-435B-4C13-A330-D732D880A4A0 Q38238941-CB47BB11-AFE0-4D46-9A31-15648190ED7A Q38264982-D1BA493C-D9F6-4C1E-9C91-58ED951DEF83 Q38435397-6B0FBA1E-E70C-4FB3-8343-E9C01586A028 Q38497066-45CCDCC7-4C25-4F2B-8817-A71AAB6D02E0 Q38602944-2F14B06B-2CC5-4041-82D7-FB6BF01FA787 Q38635910-D3BE281F-57F8-4E31-B85B-FBB3331816C2 Q38677232-5FA9CD1F-A29A-48D3-A75E-491596D43775 Q38810926-F472BACC-146F-456D-B3AB-5FBA8A4CF71D Q38833469-E1C2765F-24B6-423A-B9B5-0D55849F4766 Q39245218-754E7DAF-7932-4673-B021-BACBBB464E03 Q39313889-C698AA01-4FD2-4849-8D3A-5F07EA8FBF7E

P2860

Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer

http://www.wikidata.org/entity/Q56965679

description

im April 2014 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 01 April 2014

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у квітні 2014

@uk

name

Presence of B Cells in Tertiar ...... y in Patients with Lung Cancer

@en

Presence of B Cells in Tertiar ...... y in Patients with Lung Cancer

@nl

type

label

Presence of B Cells in Tertiar ...... y in Patients with Lung Cancer

@en

Presence of B Cells in Tertiar ...... y in Patients with Lung Cancer

@nl

prefLabel

Presence of B Cells in Tertiar ...... y in Patients with Lung Cancer

@en

Presence of B Cells in Tertiar ...... y in Patients with Lung Cancer

@nl

P1433

Q56965679-6B6E3177-6696-42C2-8C7C-03A14785E213

P1476

Q56965679-4B181381-991F-4E19-9211-ADD5FA4D52A7

P2093

Q56965679-0C2514CB-BC3D-4BF3-91F9-8F90EB4EBE1A

Q56965679-12A6F175-4965-48B8-A91F-94A07F4BE41D

Q56965679-13029FF0-01D1-4BBA-B80D-64498C178F45

Q56965679-414A1F4E-5BC3-4AA1-B85F-D31162A83E71

Q56965679-610C2763-B725-41B0-B7F4-8DB0B0A4A09B

Q56965679-640DB3E9-C77C-4CD2-A5FB-75FC132D5C92

Q56965679-78047C76-D571-4338-953C-440A64FCD6FA

Q56965679-7EA02053-B805-45D1-BF1D-DD15BF800560

Q56965679-B3A1020A-F091-468B-8ED0-72FE2BC612CB

Q56965679-C8AF1E1D-29F6-42F2-AD65-16EC1E76EDD1

P2860

Q56965679-09C8A577-A5EC-4A2D-AAA1-091E07534733

Q56965679-0F6A8D79-5A1A-44DE-A9F6-0C6B37940FEF

Q56965679-18AA03DF-5AD1-4C51-B7DB-92D536D79685

Q56965679-2944F6DD-B051-4F7D-8143-0256D537825B

Q56965679-2F1198D8-E0CF-4F8D-8364-766801686D9A

Q56965679-314BE1B5-87C3-4E6E-B49F-8F4A5806DCF0

Q56965679-32C4AF12-AC51-429D-8B97-BE2588EB20D0

Q56965679-38E8C7E4-BE80-406D-B915-F26ADF5A0D53

Q56965679-3FCDCDA4-01CD-4F71-A1EF-C3D8E10ED710

Q56965679-4247931F-A81F-425D-8678-22280590E41C

P304

Q56965679-1880EA3C-FE71-4C63-9231-417D7F691807

P31

Q56965679-82020C18-77DB-4966-BEC0-C9DC4A750FBA

P356

Q56965679-ACA764E2-B936-494A-8ED6-860EBDE91F14

P407

Q56965679-2E777EC9-67F8-480D-B07D-9F55F161AAFF

P433

Q56965679-C4AC6D5B-E402-40B3-9A79-D29F0054D5C3

P478

Q56965679-CBF9DFA7-5BC2-4498-A19A-A5215EE5BC0F

P50

Q56965679-2BBC6F2B-6B01-422C-884A-6482B2BED585

Q56965679-31729090-11D5-4743-B163-3648AF957220

Q56965679-63BF96BF-8EDD-4811-A894-9EF70A935B9F

Q56965679-8B77BE88-43EC-478D-B6FA-B0FD2F6EF00F

Q56965679-A1DE8BA7-6E7C-4DE2-9ACB-95CD2236C399

Q56965679-BB137F3F-97A8-4DB9-9081-BAADCC790D98

P577

Q56965679-F3684BCA-F600-4F0D-88FA-2A2B6A9DFFC1

P698

Q56965679-045A5975-9F73-43C6-B868-FA0FBFB14736

P921

Q56965679-AB5DB70B-FF19-4948-ABE2-6945BCEEBCC7

P356

RCCM.201309-1611OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Presence of B cells in tertiar ...... y in patients with lung cancer

@en

P2093

Claire Germain

http://www.w3.org/2001/XMLSchema#string

Diane Damotte

http://www.w3.org/2001/XMLSchema#string

Etienne Becht

http://www.w3.org/2001/XMLSchema#string

Fella Tamzalit

http://www.w3.org/2001/XMLSchema#string

Geoffray Bizouard

http://www.w3.org/2001/XMLSchema#string

Jean-Luc Teillaud

http://www.w3.org/2001/XMLSchema#string

Marco Alifano

http://www.w3.org/2001/XMLSchema#string

Marie-Caroline Dieu-Nosjean

http://www.w3.org/2001/XMLSchema#string

Pierre Magdeleinat

http://www.w3.org/2001/XMLSchema#string

Pierre Validire

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

The immune contexture in human tumours: impact on clinical outcome

Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma

Novel ganglioside antigen identified by B cells in human medullary breast carcinomas: the proof of principle concerning the tumor-infiltrating B lymphocytes.

B cells as antigen presenting cells.

Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patients.

Seromic profiling of ovarian and pancreatic cancer.

Circulating human B and plasma cells. Age-associated changes in counts and detailed characterization of circulating normal CD138- and CD138+ plasma cells.

Antibody responses to NY-ESO-1 in primary breast cancer identify a subtype target for immunotherapy.

P304

832-844

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.201309-1611OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

189

http://www.w3.org/2001/XMLSchema#string

P50

Isabelle Cremer

Catherine Sautès-Fridman

Wolf Hervé Fridman

Sandrine Katsahian

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24484236

http://www.w3.org/2001/XMLSchema#string

P921